Exchanges At Goldman Sachs
The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:26:30
- More information
Informações:
Synopsis
Goldman Sachs Research’s Chris Shibutani and Jason English explain the business and investor implications of the latest anti-obesity medications and their ripple effects in the healthcare industry and beyond.